Cargando…

Should aspirin be replaced with ADP blockers and anti-GPVI to manage thrombosis?

Platelets have a pivotal role in maintaining cardiovascular homeostasis. They are kept docile by endothelial-derived mediators. Aberration in haemostatic balance predisposes an individual to an elevated risk of a prothrombotic environment. Anti-platelet therapy has been a key component to reduce thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Hafsa, Ghulam, Tahira, Ahmed, Naseer, Rafai Babar, Muhammad, Calaminus, Simon DJ, Zuhair Yusuf, Muhammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986383/ https://www.ncbi.nlm.nih.gov/pubmed/37931411 http://dx.doi.org/10.1530/VB-22-0010

Ejemplares similares

Luteolin inhibits GPVI-mediated platelet activation, oxidative stress, and thrombosis
por: Ye, Yujia, et al.
Publicado: (2023)

Characterization of GPVI- or GPVI-CD39-Coated Nanoparticles and Their Impact on In Vitro Thrombus Formation
por: Nestele, Jeremy A., et al.
Publicado: (2021)

Anti‐GPVI nanobody blocks collagen‐ and atherosclerotic plaque–induced GPVI clustering, signaling, and thrombus formation
por: Jooss, Natalie J., et al.
Publicado: (2022)

Comparison of the GPVI inhibitors losartan and honokiol
por: Onselaer, Marie-Blanche, et al.
Publicado: (2019)

Clustering of glycoprotein VI (GPVI) dimers upon adhesion to collagen as a mechanism to regulate GPVI signaling in platelets
por: Poulter, N. S., et al.
Publicado: (2017)

Gene Targeting Implicates Cdc42 GTPase in GPVI and Non-GPVI Mediated Platelet Filopodia Formation, Secretion and Aggregation
por: Akbar, Huzoor, et al.
Publicado: (2011)

Targeting GPVI as a novel antithrombotic strategy
por: Andrews, Robert K, et al.
Publicado: (2014)

Rac Inhibition Causes Impaired GPVI Signalling in Human Platelets through GPVI Shedding and Reduction in PLCγ2 Phosphorylation
por: Neagoe, Raluca A. I., et al.
Publicado: (2022)

Thrombosis and Aspirin: Clinical Aspect, Aspirin in Cardiology, Aspirin in Neurology, and Pharmacology of Aspirin
por: Doutremepuich, Christian
Publicado: (2012)

Type 2 Diabetes and ADP Receptor Blocker Therapy
por: Samoš, Matej, et al.
Publicado: (2016)

Differential Inhibition of Human Atherosclerotic Plaque–Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies
por: Jamasbi, Janina, et al.
Publicado: (2015)

mTOR regulates GPVI-mediated platelet activation
por: Wang, Longsheng, et al.
Publicado: (2021)

GPVI expression is linked to platelet size, age, and reactivity
por: Veninga, Alicia, et al.
Publicado: (2022)

Evaluation of the effect of eltrombopag therapy on the platelet collagen receptor glycoprotein VI (GPVI) expression and soluble GPVI levels in young patients with immune thrombocytopenia
por: Tantawy, Azza Abdel Gawad, et al.
Publicado: (2022)

Discovery of Novel GPVI Receptor Antagonists by Structure-Based Repurposing
por: Taylor, Lewis, et al.
Publicado: (2014)

Human Platelet Protein Ubiquitylation and Changes following GPVI Activation
por: Unsworth, Amanda J., et al.
Publicado: (2019)

Platelet GPVI (Glycoprotein VI) and Thrombotic Complications in the Venous System
por: Perrella, Gina, et al.
Publicado: (2021)

Targeting platelet GPVI with glenzocimab: a novel mechanism for inhibition
por: Billiald, Philippe, et al.
Publicado: (2022)

ADP: the missing link between thrombosis and hemolysis
por: Gerber, Gloria F., et al.
Publicado: (2023)

Dynamin 2 is required for GPVI signaling and platelet hemostatic function in mice
por: Eaton, Nathan, et al.
Publicado: (2020)

Procoagulant platelet sentinels prevent inflammatory bleeding through GPIIBIIIA and GPVI
por: Kaiser, Rainer, et al.
Publicado: (2022)

Differential Requirement for LAT and SLP-76 in GPVI versus T Cell Receptor Signaling
por: Judd, Barbi A., et al.
Publicado: (2002)

Differential roles for the adapters Gads and LAT in platelet activation by GPVI and CLEC-2
por: HUGHES, C E, et al.
Publicado: (2008)

Antiplatelet Activity of Tussilagone via Inhibition of the GPVI Downstream Signaling Pathway in Platelets
por: Zhou, Jing, et al.
Publicado: (2020)

Aspirin Prophylaxis for the Prevention of Thrombosis: Expectations and Limitations
por: Rao, Gundu H. R., et al.
Publicado: (2012)

Should deep venous thrombosis prophylaxis be used in fast-track hip and knee replacement?
por: Kjærsgaard-Andersen, Per, et al.
Publicado: (2012)

Should β-blockers be used in septic shock?
por: Lira, Alena, et al.
Publicado: (2014)

Aspirin thromboprophylaxis in joint replacement surgery
por: Sharda, Anish V., et al.
Publicado: (2022)

α2β1 Integrin, GPVI Receptor, and Common FcRγ Chain on Mouse Platelets Mediate Distinct Responses to Collagen in Models of Thrombosis
por: Marjoram, Robin J., et al.
Publicado: (2014)

Identification of a major GpVI-binding locus in human type III collagen
por: Jarvis, Gavin E., et al.
Publicado: (2008)

Non-genomic effects of PPARγ ligands: inhibition of GPVI-stimulated platelet activation
por: Moraes, L A, et al.
Publicado: (2010)

The role of Nox1 and Nox2 in GPVI-dependent platelet activation and thrombus formation()
por: Walsh, T.G., et al.
Publicado: (2014)

Regulation of Early Steps of GPVI Signal Transduction by Phosphatases: A Systems Biology Approach
por: Dunster, Joanne L., et al.
Publicado: (2015)

Tetraspanin Tspan9 regulates platelet collagen receptor GPVI lateral diffusion and activation
por: Haining, Elizabeth J., et al.
Publicado: (2016)

GPVI (Glycoprotein VI) Interaction With Fibrinogen Is Mediated by Avidity and the Fibrinogen αC-Region
por: Xu, Rui-Gang, et al.
Publicado: (2021)

The Proteoglycan Biglycan Modulates Platelet Adhesion and Thrombus Formation in a GPVI-Dependent Manner
por: Hoermann, Henrike, et al.
Publicado: (2021)

The GPIbα intracellular tail - role in transducing VWF- and collagen/GPVI-mediated signaling
por: Constantinescu-Bercu, Adela, et al.
Publicado: (2021)

Targeting of a Conserved Epitope in Mouse and Human GPVI Differently Affects Receptor Function
por: Navarro, Stefano, et al.
Publicado: (2022)

Should We Use Dialyzable β-Blockers in Hemodialysis?
por: Georgianos, Panagiotis I., et al.
Publicado: (2022)

The GPVI-Fc Fusion Protein Revacept Improves Cerebral Infarct Volume and Functional Outcome in Stroke
por: Goebel, Silvia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6kgb8k48igijjie7gklvv9b4b1